非酒精性脂肪肝
转录因子
FOXO3公司
癌症研究
和平号-155
蛋白激酶B
肝细胞
内科学
小RNA
生物
脂肪肝
细胞生物学
信号转导
医学
体外
基因
疾病
生物化学
作者
Xiaolin Liu,Qin Pan,Haixia Cao,Feng‐Zhi Xin,Zehua Zhao,Rui‐Xu Yang,Jing Zeng,Huiping Zhou,Jian‐Gao Fan
出处
期刊:Hepatology
[Lippincott Williams & Wilkins]
日期:2019-11-29
卷期号:72 (2): 454-469
被引量:315
摘要
BACKGROUND AND AIMS: Hepatic macrophages can be activated by many factors such as gut-derived bacterial components and factors released from damaged hepatocytes. Macrophage polarization toward a proinflammatory phenotype (M1) represents an important event in the disease progression of nonalcoholic fatty liver disease (NAFLD). However, the underlying molecular mechanisms remain incompletely understood. Exosomes have been identified as important mediators for cell-cell communication by transferring various biological components such as microRNAs (miRs), proteins, and lipids. The role of exosomes in crosstalk between hepatocytes and macrophages in disease progression of NAFLD is yet to be explored. APPROACH AND RESULTS: ) activation and increase of inducible nitric oxide synthase, interleukin 6, and tumor necrosis factor alpha expression. Furthermore, hepatocyte-derived exosomal miR-192-5p inhibited the protein expression of the rapamycin-insensitive companion of mammalian target of rapamycin (Rictor), which further inhibited the phosphorylation levels of Akt and forkhead box transcription factor O1 (FoxO1) and resulted in activation of FoxO1 and subsequent induction of the inflammatory response. CONCLUSIONS: Hepatocyte-derived exosomal miR-192-5p plays a critical role in the activation of proinflammatory macrophages and disease progression of NAFLD through modulating Rictor/Akt/FoxO1 signaling. Serum exosomal miR-192-5p represents a potential noninvasive biomarker and therapeutic target for nonalcoholic steatohepatitis.
科研通智能强力驱动
Strongly Powered by AbleSci AI